| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Hôpital Jules Gonin, Department of Ophthalmology, 2 Division Autonome de Génétique Médicale, CHUV, Lausanne, Switzerland; 3 Augenklinik, Inselspital, Bern, Switzerland; the 4 Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee; 5 The Hospital for Sick Children, University of Toronto, Toronto, Canada; 6 Academic Unit, Manchester Royal Eye Hospital and Department of Molecular Genetics, St. Mary’s Hospital, Manchester, United Kingdom; 7 Clinica Oculistica, Università de L’Aquila, L’Aquila, Italy; 8 Klinik und Poliklinik für Augenheilkunde, Universität Regensburg, Regensburg, Germany; 9 Centro di Oftalmologia Barraquer, Barcelona, Spain; 10 Institute of Human Genetics, University of Greifswald, Greifswald, Germany; 11 Universitäts-Augenklinik, Zurich, Switzerland; 12 Clinica Oculistica, Università degli Studi di Cagliari, Cagliari, Italy; and the 13 Wills Eye Hospital, Philadelphia, Pennsylvania.
PURPOSE. To investigate the molecular pathology underlying BIGH3-related corneal dystrophies (CDs) and to further delineate genotype-phenotype specificity.
METHODS. Sixty-one index patients with CDs were subjected to phenotypic and genotypic characterization. The corneal phenotypes of all patients were assessed by biomicroscopy and documented by slit lamp photography. The BIGH3 gene was amplified exon by exon from constitutional DNA to perform single-strand conformation polymorphism (SSCP) analysis, followed by direct bidirectional sequencing of abnormal conformers.
RESULTS. The phenotypes of CDs were classified as lattice CD in 30 patients, Groenouw type I in 12 (CDGGI), Avellino in 7 (CDA), Reis-Bückler in 8 (CDRB), and Thiel-Behnke in 4 (CDTB). Fifty occurrences of 16 distinct mutations were identified, including 8 novel mutations responsible for lattice type IIIA in three patients (CDLIIA), intermediate type I/IIIA (CDLI/IIIA) in four patients, and atypical CDL with deep deposits in one patient (CDL-deep).
CONCLUSIONS. Disease-causing mutations were identified in 80% of the patients (50/61). All mutations localize in two regions of kerato-epithelin: the amino acid R124 and BIGH3 fasc domain 4. This study also confirms the mutation hot spot at positions R124 and R555 with nearly 50% of the mutations targeting these two amino acids (24/50). In addition the corneal phenotypes induced by changes at R124 and R555 are amino acid specific: R124C in CDLI, R555W and R124S in CDGGI, R124H in CDA, R124L in CRRB, and R555Q in CDTB. In CDLIIIA, CDLI/IIIA, and CDL-deep the genotype-phenotype correlation is domain specific, with all changes occurring at the boundary or within the fasc4 domain.
This article has been cited by other articles:
|
|
 |
|
  A. J. Aldave, V. S. Yellore, B. Sonmez, N. Bourla, A. K. Salem, M. A. Khan, S. A. Rayner, and B. J. Glasgow A Novel Variant of Combined Granular-Lattice Corneal Dystrophy Associated With the Met619Lys Mutation in the TGFBI Gene Arch Ophthalmol, March 1, 2008; 126(3): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Pedersen and D. E. Otzen Amyloid a state in many guises: Survival of the fittest fibril fold Protein Sci., January 1, 2008; 17(1): 2 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E N Hilton, G C M Black, F D C Manson, D F Schorderet, and F L Munier De novo mutation in the BIGH3/TGFB1 gene causing granular corneal dystrophy Br. J. Ophthalmol., August 1, 2007; 91(8): 1083 - 1084. [Full Text] [PDF]
|
|
|
|
|
|
A. J. Aldave and B. Sonmez Elucidating the Molecular Genetic Basis of the Corneal Dystrophies: Are We There Yet? Arch Ophthalmol, February 1, 2007; 125(2): 177 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Udar, S. R. Atilano, D. J. Brown, B. Holguin, K. Small, A. B. Nesburn, and M. C. Kenney SOD1: A Candidate Gene for Keratoconus. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3345 - 3351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kannabiran, M. S. Sridhar, S. K. Chakravarthi, G. K. Vemuganti, and M. Lakshmipathi Genotype-Phenotype Correlation in 2 Indian Families With Severe Granular Corneal Dystrophy Arch Ophthalmol, August 1, 2005; 123(8): 1127 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Yamada, T-i Chikama, N Morishige, R Yanai, T Nishida, M Inui, and K Seki Homozygous mutation (L527R) of TGFBI in an individual with lattice corneal dystrophy Br. J. Ophthalmol., June 1, 2005; 89(6): 771 - 773. [Full Text] [PDF]
|
|
|
|
|
|
B. Stix, M. Leber, P. Bingemer, C. Gross, J. Ruschoff, M. Fandrich, D. F. Schorderet, C. K. Vorwerk, M. Zacharias, A. Roessner, et al. Hereditary Lattice Corneal Dystrophy Is Associated with Corneal Amyloid Deposits Enclosing C-Terminal Fragments of Keratoepithelin Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1133 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. V. K. Chakravarthi, C. Kannabiran, M. S. Sridhar, and G. K. Vemuganti TGFBI Gene Mutations Causing Lattice and Granular Corneal Dystrophies in Indian Patients Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 121 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Klintworth, W. Bao, and N. A. Afshari Two Mutations in the TGFBI (BIGH3) Gene Associated with Lattice Corneal Dystrophy in an Extensively Studied Family Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1382 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Warren, A. J. Aldave, M. Srinivasan, E. J. Thonar, A. B. Kumar, V. Cevallos, J. P. Whitcher, and T. P. Margolis Novel Mutations in the CHST6 Gene Associated With Macular Corneal Dystrophy in Southern India Arch Ophthalmol, November 1, 2003; 121(11): 1608 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Carr, M. J. Bloemink, E. Dentten, A. O. Whelan, S. V. Gordon, G. Kelly, T. A. Frenkiel, R. G. Hewinson, and R. A. Williamson Solution Structure of the Mycobacterium tuberculosis Complex Protein MPB70: FROM TUBERCULOSIS PATHOGENESIS TO INHERITED HUMAN CORNEAL DISEASE J. Biol. Chem., October 31, 2003; 278(44): 43736 - 43743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morand, V. Buchillier, F. Maurer, C. Bonny, Y. Arsenijevic, F. L. Munier, and D. F. Schorderet Induction of Apoptosis in Human Corneal and HeLa Cells by Mutated BIGH3 Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2973 - 2979. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
